COBI Announces Immanent Acquisition and Management
Post# of 72711
Posted On: 03/08/2016 8:35:28 AM
COBI Announces Immanent Acquisition and Management Change Baystreet.ca "Standard Equities Feed"
SALT LAKE CITY UT / ACCESSWIRE / March 8, 2016 / Compass Biotechnologies Inc. (OTC PINK: COBI) (PINKSHEETS: COBI) (Compass) Compass Biotechnologies Inc.
Compass Biotechnologies Inc. , (OTC PINKSHEETS: COBI.PK): The Company expects to finalize the acquisition of EFS Audio and its Motion Sound product line by week's end, at which time, Mr. Shykora will be tendering his formal resignation, and will be appointing a new interim CEO.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
Contact Person:
Rick Shykora
At: compassbiotechnologies@gmail.com
(972) 535-8931
SOURCE: Compass Biotechnologies Inc.
SALT LAKE CITY UT / ACCESSWIRE / March 8, 2016 / Compass Biotechnologies Inc. (OTC PINK: COBI) (PINKSHEETS: COBI) (Compass) Compass Biotechnologies Inc.
Compass Biotechnologies Inc. , (OTC PINKSHEETS: COBI.PK): The Company expects to finalize the acquisition of EFS Audio and its Motion Sound product line by week's end, at which time, Mr. Shykora will be tendering his formal resignation, and will be appointing a new interim CEO.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
Contact Person:
Rick Shykora
At: compassbiotechnologies@gmail.com
(972) 535-8931
SOURCE: Compass Biotechnologies Inc.
(0)
(0)Scroll down for more posts ▼